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It is unclear whether the reverse-direction myosin
(myosin VI) functions as a monomer or dimer in
cells and how it generates largemovements on actin.
We deleted a stable, single-a-helix (SAH) domain
that has been proposed to function as part of a lever
arm to amplify movements without impact on in vitro
movement or in vivo functions. Amyosin VI construct
that used this SAH domain as part of its lever arm
was able to take large steps in vitro but did not
rescue in vivo functions. It was necessary for myosin
VI to internally dimerize, triggering unfolding of a
three-helix bundle and calmodulin binding in order
to step normally in vitro and rescue endocytosis
and Golgi morphology in myosin VI-null fibroblasts.
A model for myosin VI emerges in which cargo bind-
ing triggers dimerization and unfolds the three-helix
bundle to create a lever arm essential for in vivo
functions.INTRODUCTION
Myosin VI is the only actin-based motor among the known clas-
ses of molecular motors (Odronitz and Kollmar, 2007) that has
been shown to move toward the minus end of actin filaments
(Wells et al., 1999). Myosin VI is ubiquitous and has been impli-
cated in a variety of cellular functions (Buss et al., 2004; Frank
et al., 2004; Sweeney and Houdusse, 2007; Chibalina et al.,
2009). Biochemical and biophysical studies have demonstrated
that a myosin VI dimer is capable of processive movement along
an actin filament (Park et al., 2006) and load-dependent
anchoring (Altman et al., 2004) and thus can fulfill a number of
specialized cell biological functions, including endocytosis
(Buss et al., 2001; Hasson, 2003; Dance et al., 2004; Inoue
et al., 2008) and maintenance of Golgi morphology and function
(Sahlender et al., 2005; Buss and Kendrick-Jones, 2008). A
fundamental question and subject of considerable controversy1522 Cell Reports 8, 1522–1532, September 11, 2014 ª2014 The Auis whether or not myosin VI functions as a monomer or dimer
in any or all of its cellular functions (Rock et al., 2005; Lister
et al., 2004; Park et al., 2006; Sweeney and Houdusse, 2010;
Bond et al., 2012).
Myosin motors move along actin filaments driven by confor-
mational changes in the motor domain associated with the
sequential release of MgATP hydrolysis products, Pi and
MgADP. These conformational changes in the motor domain
are amplified by the myosin lever arm, which is comprised of
the C-terminal subdomain of the motor domain (known as the
converter) and a helix of variable length, depending on the
myosin class, to which calmodulin and/or calmodulin-like light
chains bind to a series of IQ motifs. Though similar in organiza-
tion as compared to other members of the myosin superfamily,
myosin VI has a number of class-specific structural elements
(Figure 1A). Most importantly, an insert (known as insert 2)
between the converter subdomain of the motor domain and
the single IQ motif binds an additional calmodulin and reposi-
tions the lever arm to reverse the directionality of myosin VI (Me´-
ne´trey et al., 2005, 2007). However, a lever arm comprised of the
myosin VI converter, the insert 2 region with associated CaM,
and the IQ motif with bound CaM would not allow a myosin VI
dimer to take 30–36 nm steps on actin, as has been observed
(Rock et al., 2001, 2005; Yildiz et al., 2004; Park et al., 2006).
Thus, some region distal to the IQ motif must function as an
extension of the myosin VI lever arm (Figures 1B–1D).
Two models have emerged that attribute the lever arm
extension to totally different structures and propose very
different regions of internal dimerization (Figures 1C and 1D),
which must occur distal to the lever arm extension. The region
following the IQ motif of approximately 80 residues forms a
three-helix bundle in monomeric myosin VI (Figure 1B).
Following the three-helix bundle of myosin VI, there is an addi-
tional domain that is predicted to form an extended, stable sin-
gle a helix (SAH) (Knight et al., 2005; Figure 1). Other classes of
myosins, including class VIIa, X, and Dictyostelium MyoM
(Knight et al., 2005; Spink et al., 2008, Baboolal et al., 2009)
also contain a SAH domain distal to their respective IQ motifs.
SAH domains have also been reported in smooth-muscle cal-
desmon (Wang et al., 1991) and have been identified in morethors
Figure 1. Schematic of Full-Length
Myosin VI
(A) In the full-length myosin VI (MVIFL), the motor
domain at the N terminus is followed by a unique
insert (insert 2) that binds the structural calcium-
bound calmodulin (Ca2+-CaM), followed by an IQ
motif that binds an apo-CaM. The IQ motif is fol-
lowed by a three-helix bundle, which has been
proposed to unfold and form an extension of the
CaM-containing lever arm when myosin VI di-
merizes (Mukherjea et al., 2009). The three-helix
bundle is followed by a region (shown in light and
dark green) that has been predicted to be a stable
single-alpha-helix (SAH) domain (Knight et al.,
2005; Spink et al., 2008) and can potentially form
an extension of the myosin VI lever arm. However,
it is been proposed that the proximal end of the
putative SAH (light green) contributes to dimer-
ization (Mukherjea et al., 2009). At the C-terminal
end of the molecule is the cargo-binding domain.
Underneath the schematic is the amino acid
sequence of the three-helix bundle and the re-
gions flanking it (N-terminal: IQ motif; C-terminal:
proximal portion of the SAH). The diagram
beneath the sequence shows the peptides that
were investigated in this study. Amutant construct
was made for this study with residues Glu942-
Glu978 (dark green region) of the SAH domain
deleted (MVIFL-DSAH). In a second mutant
construct, MVIFL-SAHmimic, residues from Glu922
to Arg940 (underlined in sequence) were replaced
with alternate acidic and basic residues (shown in
light green bar under sequence) to create a
consensus SAH. The red asterisk denotes the
position of leucine 926, which when mutated to a
glutamine, causes congenital deafness in humans
(Brownstein et al., 2014).
(B) Structure of the myosin VI three-helix bundle.
The residues that, when mutated, destroyed CaM
binding are shown in red. The region containing
these residues was disordered in the crystallo-
graphic structure of three-helix bundle (RCSB
accession number 3GN4). They are shown as part of the helix in the figure according to the NMR structure of three-helix bundle (RCSB accession
number 2LD3).
(C) Model of myosin VI dimer with folded three-helix bundle. The model for the myosin VI dimer proposed by Spink et al. (2008), which employs the SAH
domain as the lever arm extension. Note that, in this model, dimerization would only occur between the cargo-binding domains and/or within the adaptor
protein bound to the cargo-binding domain.
(D) Model of myosin VI dimer with unfolded three-helix bundle. The model for the myosin VI dimer proposed by Mukherjea et al. (2009), which uses the unfolded
three-helix bundle as the lever arm extension. Note that, in this model, dimerization must occur immediately following the unfolded three-helix bundle.
(E) Modified model of the myosin VI dimer. Based on the experiments described in this study, we propose modifications to our previous model of the myosin
VI dimer (illustrated in Figure 1D). On the left, two folded monomers are depicted with the folding stabilized by interactions with the SAH (Spink et al., 2008).
We propose that dimerization is initiated when two folded monomers encounter a cargo that places their cargo-binding domains in close proximity (Phichith
et al., 2009). This close proximity allows dimerization to begin at the region immediately proximal to the SAH (light green in dimer cartoon) and then propagate
into the third helix of the bundle (light blue), triggering the bundle’s unfolding. The unfolded bundle exposes a submicromolar affinity CaM-binding site
between the first and second helices of the bundle, which recruits a free CaM. This CaM binding, coupled with participation of the third helix in dimerization,
leads to stabilization of the unfolded bundle. Because there will be helical segments that are not covered by CaM or participating in dimerization, these likely
contribute flexibility to the lever arm, although it will be relatively inextensible.than 123 different proteins (Sivaramakrishnan et al., 2008). The
predicted SAH domains of these myosins typically contain
alternating clusters of negatively charged acidic and positively
charged basic amino acids typically in i, i+4 arrangements
(Knight et al., 2005, Spink et al., 2008). It has been suggested
that SAH domains are sufficiently stiff to function as mechani-
cal extensions of the myosin lever arms and can thus provideCell Refor the bulk of the lever arm extension necessary for the large
step sizes of myosin VI (Sivaramakrishnan et al., 2009). In the
model of Spink et al. (2008), depicted in Figure 1C, the myosin
VI lever arm extension consists of the combination of the
folded three-helix bundle and the SAH that follows it. Dimeriza-
tion was proposed to occur within the cargo-binding domain,
distal to the SAH (Spink et al., 2008).ports 8, 1522–1532, September 11, 2014 ª2014 The Authors 1523
Table 1. Actin-Activated ATPase Activity and Dimerization of Myosin VI Constructs
Construct Vmax (Head
1 s1) KATPase (mm)
After Actin Saturation
Vmax (Head
1 s1) KATPase (mm) % Dimers (EM)
MVIFL 5.4 ± 0.28 9.5 ± 1.3 3.5 ± 0.14 5.9 ± 1.9 17 ± 2
a,b
MVIFL-DSAH 4.6 ± 0.12 8.8 ± 0.6 2.5 ± 0.2 4.7 ± 1.2 38 ± 9
a
MVIFL-SAHmimic 5.9 ± 0.13 8.3 ± 0.5 4.8 ± 0.2 10.7 ± 1.1 0 ± 0
a
MVI917 (truncated monomer or S1) 5.8 ± 0.22 12.1 ± 3.6 NA NA 9 ± 6
a,b
MVI991+zipper 3.0 ± 0.04 3.2 ± 1.5 NA NA ND
MVI991+zipper-SAHmimic 3.2 ± 0.10 2.6 ± 1.2 NA NA ND
ATPase values are expressed as mean values (±SD) of three to five independent protein preparations shown for each construct and condition. NA, not
applicable; ND, not determined.
aRotary shadowing EM results are mean values (±SD) for each construct and condition. Data were obtained from a single spray experiment; two to five
electron micrographs and 100–500 molecules were inspected. See also Figure S1.
bValues taken from Park et al. (2006).In an alternativemodel proposedbyMukherjea et al. (2009), the
lever arm extension for myosin VI is created by unfolding of the
three-helix bundle upon myosin VI dimerization, as depicted in
Figure 1D. In this model, dimerization between two myosin VI
monomers occurs immediately distal to the three-helix bundle.
Thus, besides the nature of the lever arm extension itself, a major
difference in the two models is the location of the internal dimer-
ization region in myosin VI. In the unfolded three-helix bundle
model, dimerization occurs prior to the SAH, and in the model
where the SAH is the major component of lever arm extension,
dimerization occurs after theSAHbetween the twocargo-binding
domains.
Note that, in both models, dimerization is weak, so that full-
length myosin VI would normally exist as a monomer (Lister
et al., 2004). It is only via interaction with its adaptor proteins,
many of which are themselves dimers (Tumbarello et al., 2013),
that dimerization between the myosin VI monomers would occur
(Spudich et al., 2007; Phichith et al., 2009). Whereas there are
two models of how myosin VI dimerizes, there also is ongoing
controversy as to whether or not myosin VI actually functions
as a dimer in cells (Lister et al., 2004; Park et al., 2006; Sweeney
and Houdusse, 2010; Bond et al., 2012). Thus, the questions we
are trying to address are whether or not myosin VI functions pri-
marily as amonomer or dimer in cells, and in either case, whether
or not it uses the SAH region as its lever arm extension or unfolds
the three-helix bundle to create the lever arm extension.
RESULTS
Deletion of the SAH Domain Does Not Affect Head
Gating and Dimerization
To probe into the role of the SAHdomain inmyosin VImotor func-
tion, we designed a full-length construct lacking 37 residues
(Glu942-Glu978) from the C-terminal end of the predicted SAH
domain (MVIFL-DSAH; Figure 1A). We preserved residues
Lys915-Arg940 thatmay be necessary for dimerization ofmyosin
VI constructs (Mukherjea et al., 2009). As shown in Table 1,
following actin clustering of the monomers, MVIFL-DSAH
exhibits gating (decreased ATPase activity per head), which is
indicative of adimericmyosin inwhich the leadheadcannot com-
plete its ATPase cycle until the rear head is released from actin.1524 Cell Reports 8, 1522–1532, September 11, 2014 ª2014 The AuBecause this dimerization is weak, clustering of myosin VI mono-
mers on actin is required to increase the effective concentration
of monomers above the low micromolar concentrations of the
ATPase assays in order to initiate this proximity-induced dimer
formation (Park et al., 2006). The average Vmax values of the
actin-activated ATPase assays obtained for the single- and
double-headedMVIFL-DSAHmutant are similar to the values ob-
tained for the wild-type full-length protein under identical condi-
tions (Table 1). The Vmax values of the dimeric MVIFL-DSAH
construct are also in agreement with the steady-state values of
the artificially zippered MVI991+zipper construct (Mukherjea et al.,
2009). These results indicate that removal of the SAH after
Arg940 does not affect gating, suggesting that the distal part of
thepredictedSAHdomain is not involved in transmitting the intra-
molecular strain required for efficient head gating.
Park et al. (2006) were able to use rotary shadowing electron
microscopy (EM) to visualize dimers of full-length myosin VI
following actin clustering. However, only about 20% of the total
population appeared to be dimers. Based on the ATPase values,
one would expect a larger percentage of dimers. However,
because the dimers are unstable, and there is a delay between
when the molecules are released from the actin and when they
are spayed on the mica surface, the EM is likely to be an under-
estimate of the number of dimers formed on actin. Nonetheless,
we examined dimer formation of MVIFL-DSAH mutant following
actin clustering, because EM can confirm the ability of a
construct to dimerize (Figure S1). As summarized in Table 1,
approximately 40% of the molecules appeared to be dimers.
Only monomer and dimers were seen, with no larger aggregates
observed.
Myosin VI Lacking the SAH Can Dimerize and
Step Processively
Single-molecule fluorescence imaging with one nanometer ac-
curacy (FIONA) (Yildiz and Selvin, 2005) assays provided further
evidence that the MVIFL-DSAH dimer was sufficiently stable to
function as a processive motor similar to its full-length wild-
type counterpart. For these assays, the myosin VI proteins
were labeled with biotin-CaM, as previously described (Park
et al., 2006). To observe the stepping dynamics, streptavidin-
conjugated quantum dots (Qdots; l = 655 nm) were attached tothors
Figure 2. Single-Molecule Motility
Step sizes and run lengths of wild-type (MVIFL) and
mutant (MVIFL-DSAH) constructs at 2 mM (ATP).
(A and B) Step size traces of (A) MVIFL and (B)
MVIFL-DSAH.
(C) Distribution of step sizes of MVIFL (black) and
MVIFL-DSAH (red). The histograms were fit to
single Gaussians, centered at (mean ± SD) 56 ±
37 nm (n = 80) for MVIFL and 62 ± 31 nm (n = 122)
for MVIFL-DSAH.
(D) Characteristic run lengths of MVIFL and MVIFL-
DSAH are 0.68 ± 0.19 mm (n = 75) and 0.72 ±
0.16 mm (n = 71), respectively, obtained from a
single exponential fit. The results are summarized
in Table S1.the biotin-labeled monomers (Ali et al., 2011) and the monomers
were bound to an actin filament in the absence of ATP to induce
dimerization. Following addition of ATP, these actin-induced
mutant dimers were capable of processive movement along
actin filaments with step sizes that were indistinguishable from
the wild-type MVIFL actin-associated dimer (Figures 2A–2C; Ta-
ble S1) or the zippered MVI991+zipper construct (Mukherjea et al.,
2009; Park et al., 2006). For theMVIFL-DSAH dimer, 31 ± 15.5 nm
(n = 122) steps were observed (Figures 2B and 2C; Table S1)
compared to the 28 ± 18.5 nm (n = 80) step sizes for the MVIFL
dimer. We are confident that this behavior arises from dimers
rather than nonspecific oligomerization. We have previously
observed that, whenmultiple motors labeled with the same color
Qdot are linked together and observed moving, it is then impos-
sible to discern individual steps (Ali et al., 2011). Additionally, the
run length distributions of the wild-type and mutant dimers were
almost identical: 0.68 ± 0.19 mm (n = 75) for MVIFL and 0.72 ±
0.16 mm (n = 71) for MVIFL-DSAH (Figure 2D; Table S1).
The Unfolded Three-Helix Bundle of Myosin VI Binds an
Additional CaM
Based on structures that reveal sources of compliance within the
myosin VI converter and insert 2, we have been able to provide a
model for the stepping behavior of the myosin VI dimer that can
account for published measurements of step-size distributions
(Me´ne´trey et al., 2012). In this modeling, we noted that the pub-
lished stepping data are best modeled if the unfolded three-helix
bundle forms a relatively inextensible lever arm extension. A
major shortcoming of the model of unfolding of the three-helix
bundle is that the helices are amphipathic, which might favor a
refolding of the bundle.
We have long noted that the inclusion of mM levels of free CaM
in the buffer is required in order for myosin VI to show its normalCell Reports 8, 1522–1532, Sepprocessive movement in single-molecule
assays (Rock et al., 2001, 2005; Park
et al., 2006). This has been puzzling
because neither the insert-2-CaM nor
the IQ-CaM readily dissociate. Further-
more, Liu et al. (2011) recently proposed
the possibility of additional CaM binding
within an unfolded three-helix bundle.
Thus, we investigated the possibilitythat, once the three-helix bundle unfolds, additional, weaker
CaM-binding site(s) may be uncovered. This could lead to
stabilization of the unfolded helices and create a more effective
lever arm. We first examined this possibility by determining the
number of CaMs that bind to our zippered myosin VI dimer at
either 1 mM or 5 mM free (CaM), bracketing the range required
for optimal single-molecule movement and within the physiolog-
ical range of free CaM in a cell (Black et al., 2004). As summa-
rized in Table S2, three CaMs bind to each heavy chain of the
zippered dimer in the presence of either 1 mM or 5 mM CaM,
consistent with a submicromolar affinity. Note that the mono-
meric myosin VI construct that contained the three-helix bundle
(truncated at Lys917), but presumably in a folded form (Mukher-
jea et al., 2009), bound only two CaMs per heavy chain.
We next substituted glycines for hydrophobic residues found
in the loop (in the folded bundle) between the first and second
helix (D851-P865) of the bundle (F853G, V856G, V857G, and
L860G), which would not impact the helices or folding of the
bundle but could remove potential interactions for CaM. This
mutation abolished the binding of the third CaM (Table S2),
thus revealing that these residues are critical for the recruitment
of this additional CaM upon unfolding of the three-helix bundle.
To determine the affinity and to delineate the binding site for
the extra CaM, we performed microscale thermophoresis
(MST) experiments with the zippered myosin VI dimer as well
as with peptides derived from the three-helix bundle and the
adjacent proximal portion of the putative SAH. We measured
the Kd using Oregon-Green-labeled CaM in the presence of
2 mM EGTA. As shown in Figure 3, the measured Kd for the
zippered myosin VI dimer is 0.67 mM. Also shown in Figure 3 is
that the peptides revealed that CaM binding requires the
proximal region of the bundle (K834-E875). The measured Kd
was 2.3 mM for peptide R849-R955 and 4.71 mM for peptidetember 11, 2014 ª2014 The Authors 1525
Figure 3. CaM-Binding Affinity to the Lever Arm Extension
Binding of Oregon green-labeled calmodulin to the myosin VI zippered
dimer (HMM) and to myosin VI peptides as quantified using microscale
thermophoresis (MST) experiments. See also Table S2. Indicated are
mean values ± SD for four to six separate experiments.K834-E875. In contrast, CaM interacted weakly with the region
distal to residue E875, with a Kd of 93.1 mM for the peptide
E875-R955 and a Kd of 1502 mM for the peptide S887-R955.
We next demonstrated that removal of the hydrophobic resi-
dues from the loop connecting helix 1 and helix 2 (denoted by
red ovals in the expanded three-helix bundle in Figure 1A), which
eliminates binding of the extra CaM to the zippered dimer
(above), also removes potential interactions for CaM in the pep-
tides. Note that this loopwas ordered in a nuclearmagnetic reso-
nance (NMR) structure of the bundle (Research Collaboratory
for Structural Bioinformatics [RCSB] accession number 2LD3),
as shown in Figure 1B. MST experiments performed with the
mutated peptide (849–955; L850A, F853A, V856A, V857A, and
L860A) detected no CaM binding. As a control and to further
delineate residues involved in CaM binding, we performed the
same experiment with a construct with comparable mutations
in the first helix of the bundle (834–875; I837A, L840A, V843A,
and L846A). These residues are denoted by green ovals in the
expanded three-helix bundle sequence of Figure 1A and shown
in red (space fill) in Figure 1B. The latter construct bound CaM
with a Kd of 4.5 mM, similar to the 8.5 mM obtained with the
wild-type peptide, indicating that these residues are not neces-
sary for strong CaM binding (Figure 3). These results support a
model in which an additional calmodulin binds to the proximal
region of the unfolded bundle that includes residues 850–860.
A Perfect SAH Destroys Myosin VI Dimerization and
Prevents Bundle Unfolding
To delineate whether the proximal part of the putative SAH
domain in myosin VI is part of a SAH or is part of a dimerization
domain in the dimer, we replaced the residues from Glu922 to
Lys935 with alternate acidic and basic residues in a full-length
construct (MVIFL-SAHmimic) to match the (i, i+4) phasing
observed in the distal part of the predicted SAH domain (Fig-1526 Cell Reports 8, 1522–1532, September 11, 2014 ª2014 The Auure 1A), creating a consensus SAH domain devoid of hydropho-
bic residues. In order to maintain the correct registry with the
legitimate SAH and to extend it, we added three additional
amino acids (one additional turn of the helix). The Vmax values
of the actin-activated ATPase activity were similar to monomeric
wild-type myosin VI, whether or not actin clustering was em-
ployed, consistent with either loss of dimerization or loss of
gating. No dimers were observed with rotary shadowing EM
(Table 1; Figure S1), consistent with loss of dimerization. Further-
more, gating was observed when a leucine zipper was intro-
duced into the zippered MVI991-SAHmimic after amino acid
991 (wild-type sequence numbering) to give MVI991+zipper-
SAHmimic. The leucine zipper will tether two monomers in
close proximity, as would occur when bound to cargoes such
as Dab2 and optineurin (Phichith et al., 2009). This zippered
MVI991+zipper-SAHmimic displayed steady-state ATPase values
that were virtually identical to a dimeric, zippered wild-type
construct (MVI991+zipper), indicative of gating (Table 1). Alto-
gether, these data suggest that the MVIFL-SAHmimic construct
fails to dimerize in the steady-state ATPase assays, but if the
monomers are tethered together, the lever arms are sufficiently
stiff to create gating between the heads.
Previously, we were able to demonstrate unfolding of the
three-helix bundle in the zippered wild-type construct by intro-
ducing solvent-exposed cysteine residues into the bundle (at
positions T845 and A880) and then labeling both residues with
tetramethylrhodamine (TMR) to measure the fluorescence (Mu-
kherjea et al., 2009). This places the two rhodamines close
enough to stack with each other and quench the fluorescence
via exciton coupling (Okoh et al., 2006). In a monomeric
construct with the bundle folded, the close proximity of the
two rhodamines led to quenching of the fluorescence. Upon
dimerization of the construct by adding a leucine zipper, the
fluorescence increased to that of two unquenched rhodamines,
consistent with unfolding of the bundle (Mukherjea et al., 2009).
When the same cysteines were engineered into the zippered
MVI991-SAHmimic construct and labeled with TMR, the fluores-
cence remained quenched (Table 2), consistent with the bundle
remaining folded.
We next analyzed the processive behavior of the MVIFL-
SAHmimic mutant in single-molecule FIONA assays. In the pres-
ence of actin clustering, no molecules exhibited processive
movement. This provides further evidence that disruption of
the putative dimerization domain immediately distal to the
three-helix bundle (residues 922–936) leads to loss of dimeriza-
tion and thus processive movement upon actin clustering. This
demonstrates that there is not sufficient interaction between
the cargo-binding domains to dimerize two monomers in the
absence of binding to an adaptor protein and further demon-
strates the involvement of the region from residues 922 to 935
in internal dimerization.
To determine the ability of the SAHmimic mutant to move proc-
essively if two monomers are held in close proximity as they
would be by cargo binding in a cell, we compared the zippered
MVI991+zipper-SAHmimic construct to the zippered wild-type
construct. When the single-molecule motility was evaluated,
the MVI991+zipper-SAHmimic was indeed processive, with a char-
acteristic run length and average step size that were notthors
Table 2. Fluorescence Changes Observed by 5-TMR Labeling of Single- or Double-Cysteine Residues Inserted in MVI991+GCN4-SAHmimic
Construct
Fluorescence Ratioa
Molar Ratio of Labeling per Myosin HeadbWithout Actin or ATP With Actin With Actin + ATP
MVI991+GCN4-SAHmimic T845C 362.7 ± 24.1 331.6 ± 33.2 342.3 ± 40.6 1.06 ± 0.02
MVI991+GCN4-SAHmimic T845C, A880C 47.7 ± 5.6 53.3 ± 9.4 57.1 ± 6.2 2.22 ± 0.37
aFluorescence changes were analyzed by a ratio of the emission values to that of the absorption values for each construct. (Values shown are
means ± SD for four separate experiments.) Absorption was measured at 552 nm, and emission was measured at 575 nm.
bThe molar ratio was calculated by comparing the myosin concentration to the concentration of the incorporated TMR.significantly different from those of the zippered wild-type
(MVI991+zipper), as shown in Figure 4 and Table S1. The average
velocities were also not different (0.30 ± 0.13mm/s versus
0.31 ± 0.13mm/s for the dimeric MVI991+zipper and the dimeric
MVI991+zipper-SAHmimic, respectively). Together, these results
indicate that, whereas there is no internal dimerization of the
MVIFL-SAHmimic mutant, forced dimerization and likely binding
to cargo adaptor proteins such as Dab2 or optineurin, which
place monomers in close proximity, should allow processive
movement.
Impact of Loss of Either the SAH or Dimerization on
Endocytosis
It has been shown that fibroblasts derived from the myosin VI-
null Snell’s waltzer (sv/sv) mice exhibit a significant defect in cla-
thrin-mediated endocytosis, which is rescued by expression of
the isoform of full-length myosin VI that is missing the large insert
(NI) that follows residue 1,036 (Puri, 2009). Because removal of a
large portion of the SAH (MVIFL-DSAH construct) did not impact
gating and processive movement under in vitro conditions, we
investigated whether endocytosis is rescued in sv/sv fibroblasts
expressing this mutant construct (NI isoform). We assessed the
uptake of horseradish peroxidase (HRP)-conjugated transferrin
(Tf-HRP) in sv/sv fibroblasts transfected with either the wild-
type MVIFL or mutant MVIFL-DSAH (Figure 5A). Density scans
of western blots from transfected cells, such as shown in Fig-
ure 5A, revealed average expression levels 57.8% ± 10.6%
and 63.0% ± 9.8% of myosin VI in wild-type cells for the MVIFL
and MVIFL-DSAH, respectively. As shown in Figure 5B, no signif-
icant differences were observed between the transferrin endocy-
tosis in sv/sv fibroblasts expressing the wild-type or the DSAH
mutant proteins. However, in our experiments, transferrin uptake
in the untransfected sv/sv fibroblasts is only slightly reduced
compared to the wild-type transfected cells (Figure 5B).
It has been reported that, in sv/sv fibroblasts in the absence
of myosin VI, transferrin uptake occurs through a clathrin-inde-
pendent, caveolae-mediated pathway (Puri, 2009). To determine
whether partial inhibition of the caveolae-mediated pathway
would allow us to better visualize rescue of clathrin-mediated
endocytosis in the sv/sv fibroblasts, transferrin uptake was
analyzed after the transfected cells were treated with the choles-
terol uptake-blocking drug, filipin, which specifically inhibits
caveolar endocytosis (Sigismund et al., 2008; Puri, 2009). The
transferrin uptake in untransfected sv/sv fibroblasts was signifi-
cantly reduced upon pretreatment with filipin (Figure 5C), indi-
cating that a caveolin-mediated pathway is active in the absence
of myosin VI as has been previously shown (Puri 2009). However,Cell Refilipin treatment did not lower the transferrin uptake in either the
wild-type or the DSAH mutant myosin-VI-transfected sv/sv
fibroblasts (Figure 5C), indicating that the SAH-deleted mutant
myosin VI can rescue the function of myosin VI in clathrin-medi-
ated endocytosis.
Because replacement of residues between Glu922 and
Glu936 with alternate acidic and basic residues in a full-length
construct to create a consensus SAH (MVIFL-SAHmimic) resulted
in loss of dimerization while preserving motor function, this
afforded us a possibility to directly assess whether or not dimer-
ization proximal to the SAH of myosin VI is necessary for its
cellular functions. We thus repeated the endocytosis assays in
sv/sv fibroblasts in the presence and absence of filipin with
cells transfected with the MVIFL-SAHmimic. Surprisingly, given
the in vitro performance of the artificially dimerized construct
(zippered MVI991+zipper-SAHmimic), there was no discernable
rescue of endocytosis in the absence of filipin and less than a
fourth of the increase in uptake obtainedwith thewild-type trans-
fection (13% increase as opposed to a 58% increase) in the
presence of filipin, despite achieving protein levels (61.9% ±
11.6% of wild-type cells) that were similar to the other trans-
fected constructs.
Impact of Removal of the SAH Domain or Preventing
Dimerization on Golgi Structure
Lack of myosin VI in sv/sv fibroblasts has been reported to result
in a significantly smaller and fragmented Golgi structure
compared to the more extensive and reticulate appearance
seen in wild-type fibroblasts (Warner et al., 2003). It has also
been shown that expression of the full-length wild-type myosin
VI in the sv/sv fibroblasts can rescue the Golgi morphology
(Warner et al., 2003). To examine the effect of the SAH deletion
on the Golgi structure, sv/sv fibroblasts were transfected with
the wild-type MVIFL, the MVIFL-DSAH mutant, or the MVIFL-
SAHmimic construct. The transfected fibroblasts were immuno-
stained with an antibody against coatomer subunit b (b-Cop),
which is primarily a cis-Golgi marker, although it is present to a
lesser extent in the trans-Golgi (Griffiths et al., 1995). In the un-
transfected sv/sv fibroblasts, the Golgi complex appeared as
dispersed short tubular or vesicular structures (Figures 5D and
S2), with markedly reduced Golgi area as compared to the
MVIFL-transfected cells (Figure S2). The Golgi area was
measured as a percentage of the total cell area (see Supple-
mental Experimental Procedures). Cells expressing either the
wild-type MVIFL or the mutant MVIFL-DSAH exhibited more
extensive Golgi structure (Figures 5D and S2), with the overall
Golgi area increasing 2-fold and 1.6-fold, respectively. Thus,ports 8, 1522–1532, September 11, 2014 ª2014 The Authors 1527
Figure 4. Run Lengths and Step Sizes of
Leucine Zipper-Dimerized Wild-Type and
MVI991+zipper-SAHmimic Constructs
(A and B) Characteristic run lengths of (A)
MVI991+zipper and (B) MVI991+zipper-SAHmimic ob-
tained from single exponential fits to the data (as
shown) were (mean ± SD) 0.56 ± 0.23 mm (n =
1,493) and 0.62 ± 0.76 mm (n = 537), respectively.
WT, wild-type.
(C and D) Step-size traces of (C) MVI991+zipper and
(D) MVI991+zipper-SAHmimic plotted as displace-
ment over time.
(E and F) Histograms of step sizes of (E)
MVI991+zipper and (F) MVI991+zipper-SAHmimic were
fit to single Gaussians, centered at (mean ± SD) 64
± 19 nm (n = 124) for MVI991+zipper and 54 ± 22 nm
(n = 108) forMVI991+zipper-SAHmimic. The results are
summarized in Table S1.compared to the wild-type transfected fibroblasts, the cells
expressing the MVIFL-DSAH protein display only a slightly
reduced Golgi size (Figures 5D and S2). In sharp contrast, the
MVIFL-SAHmimic construct was not able to rescue Golgi
morphology (Figures 5D and S2) and the overall Golgi area was
indistinguishable from that of the untransfected cells (Figure 5D).
In a few cells, as shown in Figure S2, there was less Golgi area
than in untransfected cells.
DISCUSSION
Model for the Myosin VI Dimer
This study has provided insights that allow us to alter the model
proposed by Mukherjea et al. (2009). On the basis of all of the
data presented herein, we propose the model in Figure 1E for
the functional dimer of myosin VI. In the model, two monomers
dimerize and the three-helix bundle unfolds, recruiting an addi-
tional CaM, as suggested by the modeling of Liu et al. (2011).
We determined that this additional CaM binds with submicromo-
lar affinity (0.67 mM) in the region that comprises hydrophobic
residues (L850, F853, V856, V857, and L860) found at the end
of the first helix of the folded bundle (Figures 1B and 3; Table
S2). This will likely stabilize the unfolded bundle to create the1528 Cell Reports 8, 1522–1532, September 11, 2014 ª2014 The Authorslever arm extension. Modifying the puta-
tive SAH to ensure that its most proximal
region conforms to a consensus SAH
(MVIFL-SAHmimic) allows us to rule out a
model in which the nature of dimerization
is purely electrostatic (Kim et al., 2010)
and, as discussed below, leads us to pro-
pose that the dimerization region involves
some combination of residues from the
distal portion of the unfolded three-helix
bundle and the proximal region of what
has been defined as the SAH, as illus-
trated in Figure 1E. Furthermore, deletion
of most of the SAH, preserving the region
necessary for dimerization, has no impact
on in vitro or in vivo function, consistentwith it being distal to the dimerization region and thus not
contributing to the lever arm extension (Figures 2 and 5B–5D; Ta-
ble S1). It now remains to be determined where the lever arm
extension ends and the dimerization region begins. Because it
is clear that the additional CaM-binding site involves the junction
of the first and second helices, it is possible that all or part of the
third helix of the bundle could contribute to a coiled coil for
dimerization. This may explain why we see a small number of di-
mers in EM with a construct that is truncated at the end of the
three-helix bundle (Table 1).
Function of the SAH Domain in Myosin VI
Even if the SAH never functions as a lever arm extension for
myosin VI in vivo, there are two types of roles that it could
play. Analogous to the long coiled coil of the myosin V isoforms
(Trybus, 2008), the SAH could act both as a spacer between the
motors and cargo as well as create the proper geometry and in-
teractions for folding in the monomeric state (Spink et al., 2008).
In smooth-muscle caldesmon, the65 residue SAHdomain acts
as a spacer and maintains the required distance between the
N-terminal myosin and CaM-binding domains and the C-termi-
nal actin and tropomyosin-binding domain (Wang et al., 1991;
Mabuchi and Wang, 1991). The SAH by definition acts as a
Figure 5. Endocytic Uptake of Transferrin and Rescue of Golgi
Morphology in Transfected sv/sv Fibroblasts
(A) Immunoblotting was performed on lysates from sv/sv fibroblasts trans-
fected with either a full-length wild-type myosin VI (MVIFL) or a mutant
construct (MVIFL-DSAH) with an anti-myosin VI. Myosin VI was not detected in
untransfected (un) cells. Fibroblasts derived from a mouse expressing myosin
VI served as a positive control.
(B) Uptake of HRP-conjugated transferrin in sv/sv fibroblasts expressing the
MVIFL, MVIFL-DSAH, or MVIFL-SAHmimic proteins was measured at different
time points. Mean data ± SD (from six experiments) are shown. The amount of
Tf-HRP internalized is expressed as a percentage of the total transferrin.
Control transferrin uptake was measured in untransfected cells.
(C) Transfected sv/sv fibroblasts were treated with filipin, and Tf-HRP inter-
nalization was measured. Mean data ± SD (n = 6) were plotted as values
normalized against the untreated controls.
Cell Respacer in the dimer because it follows the internal dimerization
region and precedes the cargo-binding domain. However, the
lack of major in vivo impact of our SAH deletion argues that
the additional spacing created between themotor and cargo do-
mains by the SAH is not necessary to allow cargo binding, at
least for the functions we probed. Whereas myosin VI does not
have a dimeric, folded ‘‘off’’ state, as observed for myosin V (Try-
bus, 2008), the SAH may be necessary for proper folding of
monomeric myosin VI, as was previously suggested (Spink
et al., 2008). Partial deletion of the SAH in our MVIFL-DSAH
construct could perturb this folding and may be the reason we
seemore dimers in EMwithMVIFL-DSAH construct as compared
to the MVIFL wild-type (Table 1). This folding could prevent
dimerization even if two monomers are in close proximity until
the monomers are unfolded by binding to cargo adaptor pro-
teins. Once the dimer disengages from these adaptor proteins,
the weak dimerization likely allows the dimer to dissociate into
monomers, which then refold.
We are not suggesting that SAH domains cannot play a role in
extending lever arms of other classes of myosin. In myosin X, the
SAH domain is part of the effective lever arm (Knight et al., 2005;
Tokuo et al., 2007), as may also be the case in Dictyostelium
MyoM (Baboolal et al., 2009).
A SAH Lever Arm Extension Can Support In Vitro
Movement but Not In Vivo Function
Our in vitro experiments clearly demonstrate that the SAH does
not function as a lever arm extension once myosin VI dimerizes
and the three-helix bundle unfolds, and our in vivo experiments
did not demonstrate any loss of function when the SAH was
deleted. We next probed whether or not the SAH domain could
serve as a lever arm extension if we prevented internal dimeriza-
tion. To do so, we created theMVI-SAHmimic constructs, in which
internal dimerization and unfolding of the three-helix bundle did
not occur (Tables 1, 2, and S1). Because the cargo-binding
domains in the absence of cargo adaptor proteins did not trigger
dimerization, we replaced the cargo-binding domain with a
leucine zipper after residue 991 to force dimerization and essen-
tially create the molecule illustrated in Figure 1C. This molecule
(MVI991+zipper-SAHmimic) was processive with run lengths nearly
identical to that of the zippered wild-type myosin VI
(MVI991+zipper), although with increased run length variability (Fig-
ure 4; Table S1). The molecule displayed gated ATPase activity
equivalent to the zippered wild-type construct (Table 1), implying
that the SAH-containing lever arm is stiff enough to prevent
completion of the power stroke of the lead head until the rear
head has detached.
Given that the SAH domain can serve as a functional lever arm
extension in vitro, we next addressed whether or not myosin VI
must internally dimerize and unfold the three-helix bundle in(D) To analyze the differences in Golgi area among the different constructs, the
amount of area covered by theGolgi in the transfected and untransfected sv/sv
fibroblasts were quantifiedwith respect to the total cell area in each case. Each
column and error bar represents the mean ± SD for 120 cells (20 cells from
each of six independent preparations of cells). *p < 0.0001 denotes statistical
differences between untransfected and transfected sv/sv cells. See also
images in Figure S2.
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order to carry out its cellular functions or if closely spaced
myosin VI monomers with folded three-helix bundles and
SAH lever arm extensions can function in vivo. To answer this
highly debated question, we examined the ability of the MVIFL-
SAHmimic construct that cannot internally dimerize and unfold
the bundle (due to replacement of the putative dimerization re-
gion with a consensus SAH) to rescue endocytosis and Golgi
morphology in fibroblasts lacking myosin VI. Given its in vitro
performance, we anticipated that the MVIFL-SAHmimic construct
would demonstrate some functionality in cells. However, it pro-
vided no rescue of either endocytosis or Golgi morphology in
myosin VI-null (sv/sv) fibroblasts (Figure 5). These results likely
explain why amyosin VI mutation within this internal dimerization
region, L926Q (Figure 1A), causes congenital deafness in hu-
mans (Brownstein et al., 2014).
The functions we chose to examine encompass the two types
of roles myosin VI is thought to play in cells: transport and
anchoring. To support endocytosis, myosin VI must act as a
vesicle transporter, whereas to support the Golgi structural link-
age to the surrounding actin network, myosin VI is likely func-
tioning primarily as load-dependent anchor (Altman et al.,
2004; Sweeney and Houdusse, 2010). Based on the outcome
of these experiments, we conclude that myosin VI must function
as a dimer and not as a monomer for its two known types of
cellular functions. We would anticipate that the myosin VI
adaptor proteins, Dab2 and optineurin, that are involved in endo-
cytosis and Golgi localization, respectively, would place the
cargo-binding domains of two MVIFL-SAHmimic constructs in
close proximity (as in Figure 1C), creating a similar geometry
as found in the zippered MVI991+zipper-SAHmimic construct.
Thus, we conclude that the lever arm extension formed by un-
folding the three-helix bundle is required for myosin VI to traffic
in cellular actin networks, even though a lever arm extension
consisting of the folded bundle and SAH is sufficient for normal
movement on a single actin filament. The critical differences
that account for this are unclear, but one can speculate that
the unfolded three-helix bundle with one weakly associated
CaM may have more flexibility than the SAH-containing lever
arm. Furthermore, based on our earlier modeling (Me´ne´trey
et al., 2012), the lever arm using the unfolded three-helix bundle
would keep the unbound head closer to the same actin filament
as the bound head, as compared to a more conventional lever
arm. This geometry may allow the myosin to function under
higher loads than can be borne by the SAH lever arm extension.
A Need for Lever Arm Diversity
A fundamental question for myosin VI and other members of the
myosin superfamily is what constraints the lever arm design cre-
ates for cellular functions, given the complexity of cellular actin
networks (Svitkina et al., 1995). The unusual lever arm design
(including the unusual converter rearrangements; Me´ne´trey
et al., 2007) that has evolved for myosin VI may be specialized
for different functional properties as compared to a more con-
ventional lever arm design, such as found in myosin Va. The
myosin VI lever arm design could favor myosin VI remaining on
the same actin filament when trafficking in a dense cellular actin
network (Sweeney and Houdusse, 2010), allowing more efficient
transport as well as load-dependent anchoring. There is in vitro1530 Cell Reports 8, 1522–1532, September 11, 2014 ª2014 The Auevidence suggesting that myosin VI does not switch actin fila-
ments as easily as myosin Va (Brawley and Rock, 2009; Ali
et al., 2013). Myosin Va and the closely related myosin Vb have
extended and relatively stiff lever arms, which may be necessary
to stall the motors and tether vesicles within actin networks
rather than smoothly transporting (Wu et al., 1998; Provance
et al., 2008). Such tethering would prevent myosin VI from being
an efficient vesicular transporter in endocytosis. Our present
study demonstrates that the unusual myosin VI lever arm design
is necessary for its in vivo function. Given that this lever arm
extension has helical regions that are likely compliant, but not
extensible, we postulate that compliance may be a necessary
feature of the lever arms of myosin motors designed to traffic
within dense cellular actin networks. Because themyosin VI lever
arm extension is deployed only upon dimerization-induced un-
folding of the three-helix bundle and calmodulin recruitment,
dimerization of myosin VI is necessary to support its cellular
functions.
EXPERIMENTAL PROCEDURES
Protein Constructs, Expression, EM, and ATPase Assays
The myosin VI constructs were generated using a porcine myosin VI cDNA
(amino acid residues 1–991) and a mouse myosin VI cDNA (spliceform without
the large insert) as templates. Details of construct design, protein expression,
and ATPase assays are presented in the Supplemental Experimental Proce-
dures. The rotary shadowing electron microscopy (EM) was performed as pre-
viously described (Park et al., 2006). See the Supplemental Experimental
Procedures.
Single-Molecule Assays
Biotin-labeled CaM was used to selectively exchange only one of the two
myosin VI CaMs in the motor domains of the wild-type or the mutant proteins
for the single-molecules studies as described before (Yildiz et al., 2004). The
processive movements of MVIFL and MVIFL-DSAH were observed on 20 ml
flow cells using total internal reflection fluorescence microscope as described
(Baker et al., 2004; Ali et al., 2011). Details of single-molecule assays and data
analysis are presented in the Supplemental Experimental Procedures.
MST Assays
The method of Wienken et al. (2010) was adapted for probing myosin VI inter-
actions with CaM. Details are presented in the Supplemental Experimental
Procedures.
Cell Culture and Transfection
Immortalized Snell’s waltzer (sv/sv) tail fibroblasts were grown on coverslips,
and transient transfections were carried out with the wild-type and mutant
myosin VI constructs using Lipofectamine 2000 (Invitrogen) following the
manufacturer’s protocol.
Immunofluorescence Studies
Details of immunofluorescent staining of the Golgi complex in the sv/sv fibro-
blasts and determination of Golgi area are presented in the Supplemental
Experimental Procedures.
Transferrin Uptake Assays
The sv/sv fibroblasts were cultured as described above on 35 mm dishes and
transfected with the wild-type or mutant myosin VI constructs. Untransfected
cells were used as a control. Transferrin uptake was carried out as described
previously (Buss et al., 2001; Damke et al., 1995). Twenty-four hours post-
transfection, the fibroblasts were serum starved by incubating in serum-free
Dulbecco’s modified Eagle’s medium for 2 hr. Cells were washed twice with
PBS and incubated with 25 mg/ml horseradish-peroxidase-conjugated trans-
ferrin (Tf-HRP) (Jackson ImmunoResearch) for various time points at 37C.thors
After the incubation, culture dishes were placed on ice and washed twice with
10 mM HCl and 150 mM NaCl to remove the cell-surface-bound transferrin.
Cells were then lysed with 0.5% Triton X-100, and the lysates were incubated
with 3,30,5,50-tetramethylbenzidine (Sigma) in the dark for 20 min. The reaction
was stopped by the addition of 1N H2SO4, and the absorbances for the un-
bound, surface-bound, and internalized fractions were quantified at 450 nm
using a microplate reader. The data were plotted as a percentage of the total
Tf-HRP internalized. Each experiment was performed in triplicate.
For the transferrin uptake studies in the presence of filipin, the transfected
sv/sv fibroblasts were serum starved for 2 hr and incubated with 1.2 mg/ml
filipin (Sigma) for 1 hr followed by Tf-HRP uptake for 5 min. Control cells
were not treated with filipin. The cells were then analyzed as described above,
and the results were plotted with the corresponding untreated controls. Data
are represented in graphs as mean ± SD for six independent sets of experi-
ments. Student’s t test calculation was used to analyze the statistical signifi-
cance of the differences among the plotted values. A value of p % 0.05 was
considered statistically significant.SUPPLEMENTAL INFORMATION
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